These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2440145)

  • 1. Differential expression of HLA-DR allospecificities on antigen specific T cell clones.
    Igarashi M; Suciu-Foca N; Ferrone S
    Tissue Antigens; 1987 Mar; 29(3):160-7. PubMed ID: 2440145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.
    Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B
    J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR3- and HLA-DR7-restricted T-cell hyporesponsiveness to gluten antigen: a clue to the aetiology of coeliac disease?
    Scott H; Hirschberg H; Thorsby E
    Scand J Immunol; 1983 Aug; 18(2):163-7. PubMed ID: 6603652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopic analysis of HLA DR molecule expression on alloreactive T-cell clones.
    Bonneville M; Moreau JF; Peyrat MA; Merdrignac G; Charron DJ; Soulillou JP
    Hum Immunol; 1988 Nov; 23(3):207-21. PubMed ID: 2466025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS; van Rood JJ; Termijtelen A
    Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes.
    Morhenn VB; Nickoloff BJ
    J Invest Dermatol; 1987 Nov; 89(5):464-8. PubMed ID: 3117903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
    Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
    Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers.
    Piccinini LA; Mackenzie WA; Platzer M; Davies TF
    J Clin Endocrinol Metab; 1987 Mar; 64(3):543-8. PubMed ID: 3102542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody recognizing a polymorphic determinant on HLA-DR antigens except DR7 and DRw9.
    Ogasawara K; Kasahara M; Nakayama T; Ishikawa N; Kunikane H; Hawkin S; Kojima H; Ikeda H; Wakisaka A; Kikuchi Y
    Tissue Antigens; 1985 Nov; 26(5):344-7. PubMed ID: 2418531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients.
    Tait BD; Mraz G; Harrison LC
    Diabetes; 1988 Jul; 37(7):926-9. PubMed ID: 3260201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
    Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
    Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect recognition of native HLA alloantigens and B-cell help.
    Suciu-Foca N; Liu Z; Harris PE; Reed EF; Cohen DJ; Benstein JA; Benvenisty AI; Mancini D; Michler RE; Rose EA
    Transplant Proc; 1995 Feb; 27(1):455-6. PubMed ID: 7533416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.